D. Turner

Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy

D. James, A. Nagrial, P. Ross, 2021, ESMO open.

Adeno-associated virus 2 infection in children with non-A–E hepatitis

Zoe J. Oliver, Holly J. Dickinson, Colin G Fink, 2022, Nature.

A pilot study of the use of mycophenolate mofetil as a component of therapy for multidrug-resistant HIV-1 infection.

M. Betts, D. Margolis, R. Lanier, 2001 .

A Pilot Study of the Use of Mycophenolate Mofetil as a Component of Therapy for Multidrug‐Resistant HIV‐1 Infection

M. Betts, D. Margolis, R. Lanier, 2001, Journal of acquired immune deficiency syndromes.

The Differential Effects of Human Immunodeficiency Virus and Hepatitis C Virus on Bone Microarchitecture and Fracture Risk

B. Adams-Huet, P. Tebas, N. Maalouf, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The addition of mycophenolate mofetil to antiretroviral therapy including abacavir is associated with depletion of intracellular deoxyguanosine triphosphate and a decrease in plasma HIV-1 RNA.

L. Shaw, D. Margolis, D. Back, 2002, Journal of acquired immune deficiency syndromes.

A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil

L. Shaw, D. Margolis, Rupinderjeet Kaur, 2006, AIDS research and therapy.